Public Health Archives - Page 3 of 35 - Boston Life Sciences Times

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

Federal Health Leaders Join Food Allergy Fund Forum to Chart Future of Research and Innovation

November 18, 2025

From the Science of Life to the Science of Skin: AV Laboratories Unveils Molecular Biotechnology Approach to Cellular Renewal

November 17, 2025

Wolters Kluwer Integrates UpToDate Lexidrug Drug Data Into UpToDate Expert AI

November 21, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Federal Health Leaders Join Food Allergy Fund Forum to Chart Future of Research and Innovation

Dexcom Reveals Global Diabetes Advocates for World Diabetes Day

Brighton Marine Launches $100,000 Basic-Needs Initiative to Support Boston Veterans

New Research: GLP-1 Therapies Could Reduce U.S. Mortality by 3.5% Over the Next Two Decades

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

Most Read

beBright Names Kyle Clay Chief Executive Officer to Lead Next Phase of Integrated Growth

Simplify Healthcare Appoints Ruchir Ranjan as Chief Executive Officer

AGC Biologics to Produce AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Diseases

Veolia to Acquire Clean Earth, Expanding U.S. Hazardous Waste Operations and Advancing Global Growth Strategy

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

Federal Health Leaders Join Food Allergy Fund Forum to Chart Future of Research and Innovation

From the Science of Life to the Science of Skin: AV Laboratories Unveils Molecular Biotechnology Approach to Cellular Renewal

Wolters Kluwer Integrates UpToDate Lexidrug Drug Data Into UpToDate Expert AI

POPULAR CATEGORY

ABOUT US

FOLLOW US